BioCryst Pharmaceuticals, Inc.
NasdaqGS:BCRX
$ 4.16
$0.00 (0.00%)
$ 4.16
$0.00 (0.00%)
End-of-day quote: 04/26/2024

BCRX - BioCryst Pharmaceuticals Stock Prediction 2025 - 2030

20 years of reliable BioCryst Pharmaceuticals stock forecast. The Wall Street analysts predict Outperform for BCRX. See at a glance whether NasdaqGS:BCRX will rise in the future.

$0.00
Forecast 2023
$4.98
Forecast 2025
$8.46
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$4.98
Forecast 2030
$8.46
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.93
Price-to-book Ratio
N/A
Market Cap
1.19B
TEV
1.63 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$14.09

BioCryst Pharmaceuticals Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

BioCryst Pharmaceuticals Stock Forecast 2023

$10.50

In the last five quarters, BioCryst Pharmaceuticals’s Price Target has fallen from $21.13 to $14.09 - a -33.32% decrease. Four analysts predict that BioCryst Pharmaceuticals’s share price will fall in the coming year, reaching $10.50. This would represent a decrease of -25.48%.

152.4%
152.4
Last update: 04/27/2024

Highest Price Target $20.00

Average Price Target $10.50

Lowest Price Target $6.00

BioCryst Pharmaceuticals Stock Predictions 2025

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Jan 2025.

In January 2025, analysts believe the stock price will be $4.52. An increase of 8.6% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Feb 2025.

In February 2025, analysts believe the stock price will be $4.56. An increase of 9.6% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Mar 2025.

In March 2025, analysts believe the stock price will be $4.60. An increase of 10.6% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Apr 2025.

In April 2025, analysts believe the stock price will be $4.64. An increase of 11.61% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in May 2025.

In May 2025, analysts believe the stock price will be $4.68. An increase of 12.61% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Jun 2025.

In June 2025, analysts believe the stock price will be $4.73. An increase of 13.61% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Jul 2025.

In July 2025, analysts believe the stock price will be $4.77. An increase of 14.62% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Aug 2025.

In August 2025, analysts believe the stock price will be $4.81. An increase of 15.62% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Sep 2025.

In September 2025, analysts believe the stock price will be $4.85. An increase of 16.62% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Oct 2025.

In October 2025, analysts believe the stock price will be $4.89. An increase of 17.63% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Nov 2025.

In November 2025, analysts believe the stock price will be $4.94. An increase of 18.63% compared to the previous month's estimate.

Stock Forecast for the Price of an BioCryst Pharmaceuticals Share in Dec 2025.

In December 2025, analysts believe the stock price will be $4.98. An increase of 19.63% compared to the previous month's estimate.

BioCryst Pharmaceuticals Stock Prediction 2030

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Jan 2030.

In Jan 2030 analysts predict a share price of $7.68. An increase of 84.57% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Feb 2030.

In Feb 2030 analysts predict a share price of $7.75. An increase of 86.27% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Mar 2030.

In Mar 2030 analysts predict a share price of $7.82. An increase of 87.98% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Apr 2030.

In Apr 2030 analysts predict a share price of $7.89. An increase of 89.68% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in May 2030.

In May 2030 analysts predict a share price of $7.96. An increase of 91.39% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Jun 2030.

In Jun 2030 analysts predict a share price of $8.03. An increase of 93.09% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Jul 2030.

In Jul 2030 analysts predict a share price of $8.10. An increase of 94.8% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Aug 2030.

In Aug 2030 analysts predict a share price of $8.17. An increase of 96.5% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Sep 2030.

In Sep 2030 analysts predict a share price of $8.25. An increase of 98.21% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Oct 2030.

In Oct 2030 analysts predict a share price of $8.32. An increase of 99.91% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Nov 2030.

In Nov 2030 analysts predict a share price of $8.39. An increase of 101.62% compared to today's share price.

Stock Prediction for the Price of One BioCryst Pharmaceuticals Share in Dec 2030.

In Dec 2030 analysts predict a share price of $8.46. An increase of 103.32% compared to today's share price.

P/E
0.00
Beta
1.93
Price-to-book Ratio
N/A
Market Cap
1.19B
TEV
1.63 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$14.09

BioCryst Pharmaceuticals Analyst Ratings Frequently Asked Questions

Who are the analysts watching BioCryst Pharmaceuticals, Inc.?

The following analysts have recently covered BioCryst Pharmaceuticals:

Barclays
BofA Global Research
Evercore ISI
H.C. Wainwright & Co.
J.P. Morgan
Jefferies LLC
JMP Securities
Marktfeld
Needham & Company
Oppenheimer & Co. Inc.
Piper Sandler Companies
RBC Capital Markets
TD Cowen
(This information refers to the last 90 days.)

Who are the sell-side analysts watching BioCryst Pharmaceuticals, Inc.?

The following sell-side analysts have recently covered BioCryst Pharmaceuticals:

Wang, Huidong
Ahmad, Tazeen
Bayko, Liisa Ann
Fein, Andrew S.
Fye, Jessica Macomber
Raycroft, Maurice Thomas
Wolleben, Jonathan Patrick
Paraskevopoulos, Michail
Belanger, Serge D.
Raymond, Christopher Joseph
Davis, Luke
Ku, Stacy
Brisebois, François Daniel
(This information refers to the last 90 days.)